Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Insiders ranked
288
Showing 50 of 288
Quality filters
10+ trades
≥3 issuers, 50% price coverage
Window
5y trailing
Trade date filter
| # | Insider | Trades | Issuers | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|
| 201 | Deerfield Management Company, L.P. (Series C) | 14 | 3 | 36% | -18.0% | -34.3% | +24.6% | -41.9% |
| 202 | Deerfield Partners, L.P. | 14 | 3 | 36% | -18.0% | -34.3% | +24.6% | -41.9% |
| 203 | Deerfield Mgmt L.P. | 14 | 3 | 36% | -18.0% | -34.3% | +24.6% | -41.9% |
| 204 | Flynn James E | 14 | 3 | 36% | -18.0% | -34.3% | +24.6% | -41.9% |
| 205 | Richman Darren | 31/33 | 3 | 10% | -16.8% | -15.5% | +24.9% | -34.3% |
| 206 | Orbimed Capital Gp VI LLC | 17/26 | 7 | 24% | -16.5% | -24.1% | +51.1% | -45.8% |
| 207 | Sandell Scott D | 11/12 | 9 | 36% | -16.1% | -11.6% | +31.3% | -63.0% |
| 208 | Geygan Jeffrey Richart | 128/133 | 3 | 19% | -15.5% | -21.3% | +47.5% | -39.1% |
| 209 | Fairmount Healthcare Fund II L.P. | 10/12 | 4 | 10% | -15.2% | -15.0% | +46.3% | -51.2% |
| 210 | Ault Milton C III | 224/302 | 5 | 34% | -14.9% | -21.5% | +97.3% | -76.9% |
| 211 | Lutnick Howard W | 11/14 | 7 | 27% | -14.6% | -6.5% | +17.0% | -38.3% |
| 212 | Chan Heng Fai Ambrose | 64/72 | 4 | 27% | -14.3% | -14.9% | +80.6% | -67.1% |
| 213 | Green Jeremy | 13/17 | 6 | 8% | -13.2% | -22.5% | +84.7% | -44.0% |
| 214 | Redmile Group, LLC | 13/17 | 6 | 8% | -13.2% | -22.5% | +84.7% | -44.0% |
| 215 | Leone Douglas M | 25 | 3 | 32% | -12.6% | -17.7% | +18.8% | -33.0% |
| 216 | Garden Edward P | 30/33 | 3 | 13% | -12.0% | -8.6% | +3.0% | -32.7% |
| 217 | Mardy Michael J | 11/12 | 3 | 64% | -11.8% | +2.8% | +11.7% | -49.5% |
| 218 | Plp Funds Master Fund LP | 183 | 3 | 27% | -11.0% | -12.1% | +28.0% | -47.7% |
| 219 | Bleichroeder LP | 44/51 | 6 | 27% | -10.7% | -19.2% | +38.9% | -34.8% |
| 220 | Ra Capital Nexus Fund II, L.P. | 51/69 | 13 | 24% | -10.4% | -19.1% | +218.7% | -69.2% |
| 221 | Barry John F | 51/61 | 3 | 4% | -10.4% | -8.6% | +3.9% | -25.5% |
| 222 | Orbimed Advisors LLC | 48/87 | 18 | 33% | -9.4% | -18.2% | +107.2% | -51.7% |
| 223 | Botha Roelof | 31/35 | 6 | 35% | -9.0% | -16.8% | +27.0% | -33.0% |
| 224 | Sc US (Ttgp), Ltd. | 79 | 4 | 30% | -8.2% | -10.1% | +18.8% | -33.0% |
| 225 | Caligan Partners LP | 25/27 | 4 | 44% | -7.9% | -17.1% | +102.1% | -57.0% |
| 226 | Johnson David Edward | 25/27 | 4 | 44% | -7.9% | -17.1% | +102.1% | -57.0% |
| 227 | Mullady Agnes | 10 | 9 | 0% | -7.8% | -5.6% | -0.3% | -17.3% |
| 228 | Ra Capital Management, L.P. | 91/129 | 31 | 34% | -6.3% | -16.0% | +218.7% | -80.4% |
| 229 | Kolchinsky Peter | 89/127 | 30 | 35% | -6.2% | -17.1% | +218.7% | -80.4% |
| 230 | Ra Capital Healthcare Fund LP | 89/127 | 30 | 35% | -6.2% | -17.1% | +218.7% | -80.4% |
| 231 | Shah Rajeev M. | 89/127 | 30 | 35% | -6.2% | -17.1% | +218.7% | -80.4% |
| 232 | Frost Gamma Investments Trust | 291 | 4 | 19% | -5.9% | -9.4% | +52.8% | -26.9% |
| 233 | Makan Divesh | 52 | 4 | 42% | -5.8% | -15.7% | +39.9% | -54.5% |
| 234 | Frost Phillip MD Et Al | 300 | 4 | 21% | -5.5% | -8.5% | +52.8% | -26.9% |
| 235 | Griffith William J.g. | 50 | 4 | 44% | -5.4% | -15.7% | +39.9% | -54.5% |
| 236 | Hellerman Gerald | 20 | 3 | 30% | -5.1% | -4.9% | +4.7% | -15.5% |
| 237 | Eberwein Jeffrey E. | 188/218 | 4 | 34% | -4.9% | -5.5% | +48.3% | -75.0% |
| 238 | Lucier Gregory T | 13/16 | 4 | 46% | -4.8% | -0.5% | +7.6% | -28.5% |
| 239 | Manning Paul B | 20 | 4 | 40% | -4.5% | -16.3% | +102.1% | -45.1% |
| 240 | Durable Capital Partners LP | 283 | 5 | 45% | -4.5% | -3.8% | +44.9% | -48.3% |
| 241 | Fund 1 Investments, LLC | 851 | 5 | 36% | -4.3% | -4.7% | +39.7% | -47.7% |
| 242 | Pleasant Lake Partners LLC | 851 | 5 | 36% | -4.3% | -4.7% | +39.7% | -47.7% |
| 243 | Schuler Jack W | 31/40 | 5 | 42% | -4.0% | -11.8% | +48.2% | -60.8% |
| 244 | Radoff Bradley Louis | 58/64 | 6 | 24% | -4.0% | -11.1% | +76.9% | -13.2% |
| 245 | Cohen Jonathan H | 31/35 | 3 | 19% | -3.9% | -3.0% | +7.5% | -14.7% |
| 246 | Rosenwald Lindsay A MD | 18 | 4 | 33% | -3.8% | -12.2% | +128.7% | -79.3% |
| 247 | Rosenthal Saul B | 32/36 | 3 | 19% | -3.8% | -3.0% | +7.5% | -14.7% |
| 248 | Gelsinger Patrick P | 26/27 | 3 | 46% | -3.8% | -0.5% | +18.1% | -40.6% |
| 249 | Lane Amy B | 15 | 3 | 40% | -3.7% | -4.9% | +29.1% | -33.8% |
| 250 | 22nw Fund Gp, LLC | 30/31 | 4 | 37% | -3.2% | -8.0% | +64.4% | -44.8% |